Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection
Open Access
- 1 December 1996
- journal article
- Published by Elsevier in The Lancet
- Vol. 348 (9041), 1547-1551
- https://doi.org/10.1016/s0140-6736(96)05283-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of InfectionScience, 1996
- Quantitation of HIV-1 RNA in Plasma Predicts Outcome after SeroconversionAnnals of Internal Medicine, 1995
- HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and TherapyScience, 1995
- Studies in Subjects with Long-Term Nonprogressive Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1995
- Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- A Strategy for Prophylactic Vaccination Against HIVScience, 1993
- A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug usersAIDS, 1990